Clinical Updates in HER2+ mBC with ASCO coverage


 

2021 ASCO Updated Results of HER2CLIMB Study: Tucatinib vs. Placebo Added to Trastuzumab & Capecitabine for Patients With Pretreated HER2+ MBC With or Without Brain Mets

468 views
July 9, 2021
0 Comments
Login to view comments. Click here to Login
Clinical Updates in HER2+ mBC with ASCO coverage